Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,393 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
KXI powers higher on risk-off flows, yet currency swings across Nestlé, Coca-Cola, Walmart and other holdings threate...
JPMorgan Chase CEO Jamie Dimon cautions that inflation could reappear if geopolitical shocks linger, rattling investo...
Markets staged a broad reversal as crude collapsed and investors priced in a potential de-escalation in a tense geopo...
Markets tremble as Iran tensions flare and policy choices loom. This report explains how trump seems have himself cou...
A notable fund trimmed its stake in Core Scientific while the stock jumped dramatically. This article breaks down wha...
The SpaceX IPO could unlock a new era for private-market access. This guide breaks down why SpaceX matters, how to ge...
A large fund trimmed its IRADIMED stake while the company posted a record quarter, sparking discussion about growth, ...
When a big shareholder starts selling, the market pays attention. This article explains what this major investor dump...
A mid‑sized fund just boosted its stake in ServiceTitan after a sharp share drop. This article unpacks what the move ...
Microsoft's stock has faced a meaningful pullback this year. This article unpacks the factors behind the drop, evalua...
A choppy week toppled many growth names, but poet technologies stock sliding captured particular attention. Here’s wh...